Nano-X Imaging Ltd. (NNOX) AI Stock Summary

Snapshot

Nano-X is a medical imaging company in severe financial distress. It generated $13.0M in revenue in FY 2025, up 15.4% from the prior year, but lost $75.0M in net income. The core hardware business has negative gross margins, meaning the company loses money on every unit it sells, while heavy R&D spending of $19.2M (148% of revenue) drives the headline losses. The company burned $45.0M in free cash flow last year and holds $59.6M in cash against $7.9M in debt. With a cash runway of only 7.9 months at current burn rates and a formal going-concern warning from management, the business faces an immediate liquidity crisis. The stock trades near its 52-week low, reflecting the market's view that the company may not survive without a major capital raise or strategic sale.

What's Happening Right Now

• Mon 29th Jun '26 · Lawsuit: A class action lawsuit was filed against Nano-X for alleged securities fraud violations related to disclosures between March 2025 and April 2026.
• Fri 26th Jun '26 · Analyst Downgrade: An analyst downgraded the stock to sell, citing a shift from growth narrative to survival mode due to persistent cash burn and execution risks.
• Thu 25th Jun '26 · Earnings & Liquidity: Nano-X reported Q1 2026 revenue of $4.3M but widened its net loss to $14.3M, withdrew its 2026 guidance, and issued a severe going-concern warning stating current cash is insufficient for the next 12 months.

Ownership

Institutions hold 18.8% of the shares, while insiders hold 0.4%.

Bottom Line

Nano-X is a high-risk speculative name facing an existential liquidity crisis. The company has issued a going-concern warning, signaling that it may not have enough cash to survive the next 12 months without raising new capital or selling assets. While revenue is growing, the business model is deeply unprofitable with negative gross margins and massive operating losses. The recent withdrawal of guidance and the filing of a securities fraud lawsuit add significant legal and operational uncertainty. A reader should view this as a distressed asset with a very short time horizon for resolution, not a standard growth investment.